AI-powered drug discovery company whose mission is to extend healthy, productive longevity for everyone. Founded in 2014. Combines AI and deep learning for target identification and therapeutic design. Dual HQ in Boston and Hong Kong. First AI-discovered drug entering Phase 2 clinical trials for idiopathic pulmonary fibrosis. *Catalogued by Claude* On this page you can view the company profile, browse linked jobs, products, posts, and ventures, inspect verification and contact details, follow related identity links.